Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target.
If You Invested $100 In This Stock 20 Years Ago, You Would Have $600 Today
Vale (NYSE:VALE) has outperformed the market over the past 20 years by 1.77% on an annualized basis producing an average annual return of 9.55%. Currently, Vale has a market capitalization of $62.37 billion.
